1. The chemistry and pharmacology of synthetic cannabinoid receptor agonists as new psychoactive substances: Origins;Banister;Handbook of Experimental Pharmacology,2018
2. Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project;Brunt;Drug Testing and Analysis,2017
3. De Morais, J., Brandt, S., Jorge, R., Christie, R., Gallegos, A., Sedefov, R., & Evans-Brown, M. (2020). EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA). https://www.emcdda.europa.eu/publications/technical-reports/technical-report-mdmb-4en-pinaca_en.
4. EMCDDA. (2017). Synthetic cannabinoids in Europe (Perspectives on drugs). https://www.emcdda.europa.eu/publications/pods/synthetic-cannabinoids_en.
5. EMCDDA. (2020a). EMCDDA initial report on the new psychoactive substance methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3- carboxamido)butanoate (MDMB-4en-PINACA). 10.2810/135998.